B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

194.29 -1.16 (-0.59%)
Official Closing Price Updated: 7:00 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,749,901
Open 195.10
Bid (Size) 191.62 (1)
Ask (Size) 194.39 (1)
Prev. Close 195.45
Today's Range 193.04 - 195.64
52wk Range 135.85 - 199.95
Shares Outstanding N/A
Dividend Yield 3.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
These companies can lend growth and dividend returns to a long-term investor's portfolio. 
Via The Motley Fool
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety

Performance

YTD
+21.57%
+21.57%
1 Month
-1.38%
-1.38%
3 Month
+16.17%
+16.17%
6 Month
+14.29%
+14.29%
1 Year
+31.77%
+31.77%

More News

Read More
3 Industries Set To Explode When Interest Rates Drop
Via Talk Markets
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
Via Benzinga
Comparing AbbVie With Industry Competitors In Biotechnology Industry
Via Benzinga
Behind the Scenes of AbbVie's Latest Options Trends
Via Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Via Benzinga
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
5 Best Dividend Growth Stocks to Buy in October
Via The Motley Fool
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
Via Investor Brand Network
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
Behind the Scenes of AbbVie's Latest Options Trends
Via Benzinga
Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition
Via FinancialNewsMedia
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
15 Best Dividend Stocks for Lifelong Passive Income
Via The Motley Fool
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Via Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Via Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Via Benzinga
Exposures Product Safety
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
Via Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
Via The Motley Fool
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Via Benzinga
Exposures Product Safety
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
Via Investor's Business Daily
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Via The Motley Fool
Topics Stocks
Exposures US Equities
Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18,
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.